Cancer Research  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 5725-5731, October 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruan, S.
Right arrow Articles by Lloyd, K. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruan, S.
Right arrow Articles by Lloyd, K. O.

Glycosylation Pathways in the Biosynthesis of Gangliosides in Melanoma and Neuroblastoma Cells: Relative Glycosyltransferase Levels Determine Ganglioside Patterns1

Shutian Ruan and Kenneth O. Lloyd2

Memorial Sloan-Kettering Cancer Center, New York, New York 10021

In order to elucidate some of the factors that determine the characteristic expression of gangliosides in malignant melanoma and neuroblastoma the levels of ganglioside synthases (glycosyltransferases) were determined in a panel of cell lines from those tumors that exhibited a wide range of ganglioside composition. Sialyltransferases (GM3, GD3, GD1a, and GT1b synthases), N-acetylgalactosaminyltransferases (GM2 and GD2 synthases), and galactosyltransferase (GM1 and GD1b synthases) were analyzed in crude membrane preparations from these cells. The results confirmed the importance of GM3 and GD3 synthases in determining the prominence of the a (GM3 to GT1a) or b (GD3 to GQ1b) biosynthetic pathways. The overall ganglioside composition in cells was found to be dependent on the relative levels of specific enzymes acting sequentially or in competing pathways. In general, the pattern and levels of transferases correlated with the actual ganglioside content of the cell line, although several important discrepancies were noted. For example, in cell lines containing high amounts of GD2 ganglioside, the level of the preceding enzyme in the pathway (GD3 synthase) was unexpectedly low. Thus, the high GD2:GD3 ratios characteristic of most neuroblastomas result from low levels of GD3 synthase as well as high levels of GD2 synthase. In other cell lines, GD3 synthase was completely absent, resulting in the synthesis of GM2, but not GD2, by N-acetylgalactosaminyltransferase I, as would be expected. It was concluded that different glycosyltransferases play key roles in determining glycolipid expression in different cell types.

1 Supported by grants from the National Cancer Institute (CA08478 and CA21445).

2 To whom requests for reprints should be addressed, at Sloan-Kettering Institute, Section 6155, 1275 York Avenue, New York, NY 10021.

Received 4/30/92. Accepted 8/ 6/92.




This article has been cited by other articles:


Home page
Clin. Chem.Home page
K. Swerts, B. De Moerloose, C. Dhooge, J. Vandesompele, C. Hoyoux, K. Beiske, Y. Benoit, G. Laureys, and J. Philippe
Potential Application of ELAVL4 Real-Time Quantitative Reverse Transcription-PCR for Detection of Disseminated Neuroblastoma Cells
Clin. Chem., March 1, 2006; 52(3): 438 - 445.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
D. Y. Wu, N. H. Segal, S. Sidobre, M. Kronenberg, and P. B. Chapman
Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells
J. Exp. Med., July 7, 2003; 198(1): 173 - 181.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. S. B. Hoon, C. T. Kuo, S. Wen, H. Wang, L. Metelitsa, C. P. Reynolds, and R. C. Seeger
Ganglioside GM2/GD2 Synthetase mRNA Is a Marker for Detection of Infrequent Neuroblastoma Cells in Bone Marrow
Am. J. Pathol., August 1, 2001; 159(2): 493 - 500.
[Abstract] [Full Text]


Home page
GlycobiologyHome page
J. Li, D. M. Rancour, M. L. Allende, C. A. Worth, D. S. Darling, J. B. Gilbert, A. K. Menon, and W. W. Young Jr.
The DXD motif is required for GM2 synthase activity but is not critical for nucleotide binding
Glycobiology, March 1, 2001; 11(3): 217 - 229.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Fukumoto, H. Miyazaki, G. Goto, T. Urano, K. Furukawa, and K. Furukawa
Expression Cloning of Mouse cDNA of CMP-NeuAc:Lactosylceramide alpha 2,3-Sialyltransferase, an Enzyme That Initiates the Synthesis of Gangliosides
J. Biol. Chem., April 2, 1999; 274(14): 9271 - 9276.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Miyazaki, S. Fukumoto, M. Okada, T. Hasegawa, K. Furukawa, and K. Furukawa
Expression Cloning of Rat cDNA Encoding UDP-galactose:GD2 beta 1,3-galactosyltransferase That Determines the Expression of GD1b/GM1/GA1
J. Biol. Chem., October 3, 1997; 272(40): 24794 - 24799.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Furukawa, H. Soejima, N. Niikawa, H. Shiku, and K. Furukawa
Genomic Organization and Chromosomal Assignment of the Human beta 1,4-N-Acetylgalactosaminyltransferase Gene. IDENTIFICATION OF MULTIPLE TRANSCRIPTION UNITS
J. Biol. Chem., August 23, 1996; 271(34): 20836 - 20844.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Yamashiro, M. Haraguchi, K. Furukawa, K. Takamiya, A. Yamamoto, Y. Nagata, K. O. Lloyd, H. Shiku, and K. Furukawa
Substrate Specificity of beta1,4-N-Acetylgalactosaminyltransferase in Vitro and in cDNA-transfected Cells
J. Biol. Chem., March 17, 1995; 270(11): 6149 - 6155.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.